Jefferies Financial Group Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Jefferies Financial Group Inc.

$10.7 Billion
Q1 2025

A detailed history of Jefferies Financial Group Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 6,623 shares of REGN stock, worth $3.23 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,623

Previous 35,822 81.51%

Holding current value

$3.23 Million

Previous $25.5 Million 83.54%

% of portfolio

0.04%

Previous 0.16%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$634.14 - $744.83 $18.5 Million - $21.7 Million	-29,199 Reduced 81.51%	6,623 $4.2 Million
Q4 2024 Feb 14, 2025	BUY	$701.85 - $1046.91 $5.84 Million - $8.72 Million	8,327 Added 30.29%	35,822 $25.5 Million
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $7.17 Million - $8.42 Million	7,004 Added 34.18%	27,495 $28.9 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $10.5 Million - $12.7 Million	11,851 Added 137.16%	20,491 $21.5 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $758,259 - $834,414	840 Added 10.77%	8,640 $8.32 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $4.26 Million - $4.85 Million	5,500 Added 239.13%	7,800 $6.85 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $5.05 Million - $6.16 Million	-7,300 Reduced 76.04%	2,300 $1.89 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $2.29 Million - $2.72 Million	-3,275 Reduced 25.44%	9,600 $6.9 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $8.39 Million - $10.2 Million	12,327 Added 2249.45%	12,875 $10.6 Million
Q4 2022 Sep 21, 2023	SELL	$705.89 - $766.39 $6.39 Million - $6.94 Million	-9,052 Reduced 94.29%	548 $395,000
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $386,827 - $419,981	548 New	548 $395,000
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $3.92 Million - $4.63 Million	-10,522 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $3.53 Million - $4.24 Million	10,522 New	10,522 $3.93 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $4.15 Million - $4.83 Million	-11,819 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $1.74 Million - $2.11 Million	6,110 Added 107.02%	11,819 $4.08 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $1.8 Million - $2.25 Million	5,709 New	5,709 $1.97 Million

Others Institutions Holding REGN

# of Institutions

1,471

Shares Held

85.8M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $52.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Account

Jefferies Financial Group Inc. Regeneron Pharmaceuticals, Inc. Transaction History